Bristol-Myers Shares Slide as Cancer-Drug Race Intensifies

(Bloomberg) -- Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo didn’t sell as well as analysts had expected in the fourth quarter, suggesting that the drugmaker is facing increasing press...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.